- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Public Companies
Duke Realty reports leasing at 5-year high
April 29, 2010
Cory SchoutenDuke Realty Corp. handled more leasing activity last quarter than it has in any first quarter in five years, the locally based
real estate
investment trust said on Wednesday.
MoreMedco Health profits climb as it adds big clients
April 28, 2010
IBJ Staff and Associated PressMedco, which operates a major pharmacy and distribution center in Whitestown, got a boost from higher prices on brand-name
drugs and from greater sales of more profitable generic drugs.
MoreDow AgroSciences' profit rises despite lower revenue
April 28, 2010
IBJ Staff and Associated PressThe Indianapolis unit of Dow Chemical sees quarterly profit rise 6 percent, to $384 million, despite an 8-percent dip in revenue.
The parent company reports strongest quarterly results in more than a year.
MoreInteractive Intelligence reports strong profit, revenue
April 28, 2010
Interactive Intelligence's quarterly profit rises to $1.9 million, a 58-percent improvement over the first three months of
last year.
MoreWellPoint profits rise, beat analysts' expectations
April 28, 2010
J.K. WallThe Indianapolis-based health insurer was helped in first quarter by a mild flu season, but it now expects to lose nearly
700,000 customers by year end.
MoreCummins profit jumps on demand from emerging markets
April 27, 2010
Scott OlsonThe Columbus-based engine maker sees sales increase in developing countries such as China, India and Brazil.
MoreCeladon reports quarterly profit on higher revenue
April 27, 2010
The Indianapolis-based trucking company saw profit rise to $400,000 in its third quarter from a $2.1 million loss in the same
period
last year.
MoreGeneral Growth hearing delayed to weigh bids
April 26, 2010
Bloomberg NewsGeneral Growth Properties Inc., the second-biggest U.S. mall owner, said a bankruptcy court hearing on its auction process
will be delayed five days to give the company time to consider competing bids, including one from Indianapolis-based Simon
Property Group.
MoreUPDATE: Emmis takeover deal unlikely to hit turbulence
April 26, 2010
Greg Andrews, Scott OlsonA big Emmis Communications Corp. shareholder believes the $90 million deal CEO Jeff Smulyan unveiled Monday morning to
take the company private is unlikely to get derailed—even though it’s worth far less than a takeover offer Smulyan
failed to get through his board four years ago.
MoreEmmis chief looks to take company private
April 26, 2010
Scott OlsonJS Acquisition Inc., the company Emmis CEO Jeff Smulyan has established to complete the acquisition, would purchase all shares
of publicly traded Emmis for about $90 million, according to Monday morning's announcement.
MoreOld National improves first-quarter performance
April 26, 2010
IBJ StaffEvansville-based Old National Bancorp on Monday reported a first-quarter profit of $10.1 million, up
84 percent from the prior-year period and a big improvement from the fourth quarter of 2009, when the company posted a loss
of $9.3 million.
MoreITT Educational posts first-quarter profit, raises forecast
April 22, 2010
J.K. WallThe Carmel-based operator of for-profit colleges pulled in profits of $85.7 million, or $2.46 per share, up nearly 44 percent
from the same quarter a year ago.
MoreShareholders fail to remove Lilly's anti-takeover provision
April 19, 2010
J.K. WallThe proposal to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly’s board received
approval from shareholders holding 74 percent of Lilly’s shares.
MoreShares fall after Lilly earnings report
April 19, 2010
J.K. WallLilly shareholders are set to gather Monday in Indianapolis to hear an update on the company’s performance, including
how it will keep paying its generous dividend during the lean years after Zyprexa’s patent expiration.
MoreLilly to pay $400M to repurchase Cymbalta rights
April 19, 2010
Bloomberg NewsEli Lilly and Co. will repurchase rights to develop and market antidepressant Cymbalta outside the U.S. and Japan from European
partner Boehringer Ingelheim for an initial payment of $400 million.
MoreHealth reform dings Lilly's earnings
April 19, 2010
J.K. WallThe Indianapolis-based drugmaker also lowered its forecast for full-year profits because the new health care law grants bigger
rebates on prescription drugs to federal health insurance programs.
MoreCan Lilly afford to maintain its dividend?
April 17, 2010
J.K. WallAs shareholders gather April 19 for Eli Lilly and Co.'s annual meeting, more of them than ever will come with an unusual question:
Will Lilly be able to keep paying its dividend?
MoreBiglari's comparisons to Buffett debated
April 17, 2010
Cory SchoutenSardar Biglari has copied some of the trademarks of his investing idol, Warren Buffett, including a folksy annual letter to
shareholders. But Biglari is just starting his career and already is showing signs of taking a different approach than that
of the Oracle of Omaha.
MoreInteractive Intelligence performance lifts CEO's pay
April 15, 2010
Peter SchnitzlerCEO Donald Brown saw a 32.4-percent increase in total compensation last year as the software-maker's shares soared 169
percent.
MoreKite Realty Group slashes CEO's pay 44 percent
April 14, 2010
Peter SchnitzlerJohn A. Kite's total compensation fell to $689,074 last year while the rest of his management team also took deep pay cuts.
MoreReport: Simon may drop General Growth bid
April 12, 2010
Bloomberg NewsShares in General Growth Properties Inc., the second-biggest U.S. mall owner, fell as much as 6.7 percent Monday morning after
a newsletter report that Simon Property Group Inc. may abandon a takeover bid for its smaller rival.
MoreSteak n Shake unveils new restaurant prototype
April 9, 2010
Cory SchoutenThe company now known as Biglari Holdings Inc. on Thursday unveiled a new prototype for future Steak n Shake restaurants.
CEO Sardar Biglari said the goal is to open about 1,500 new franchise locations in the coming years.
MoreUPDATE: Steak n Shake shareholders OK name change
April 8, 2010
Cory SchoutenSteak n Shake Co. shareholders on Thursday approved changing the parent company’s name to Biglari Holdings Inc. Shares
begin trading under the new name on Friday.
MoreSteak n Shake CEO woos investors in New York City
April 8, 2010
Cory SchoutenSteak n Shake Co. doesn't operate a single restaurant in New York City, where it is hosting its annual meeting Thursday.
But the world financial capital is chock full of high-profile investors intrigued by Steak n Shake CEO Sardar Biglari's
plans to harvest cash from the 485-location restaurant chain and deploy it on other investments.
MoreBrightpoint cuts CEO's pay by almost 35 percent
April 5, 2010
Peter SchnitzlerRobert J. Laikin earned $2.2 million in 2009, nearly 35 percent less than in 2008. Several other members of his management
team also took
substantial pay cuts.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.